Related Experiment Video
Updated: Feb 25, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease
Benzi M Kluger1, Sanjana Garimella1, Cynthia Garvan2
1Department of Neurology of the University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Objective:
Fatigue is a common and debilitating symptom of Parkinson's disease (PD) with no evidence-based treatments. While several fatigue scales are partially validated in PD the minimal clinically important difference (MCID) is unknown for any scale but is an important psychometric value to design and interpret therapeutic trials. We thus sought to determine the MCID for the Modified Fatigue Impact Scale (MFIS).
Methods:
This is a secondary data analysis from 94 PD participants in an acupuncture trial for PD fatigue. Standard psychometric approaches were used to establish validity and an anchor-based approach was used to determine the MCID.
Results:
The MFIS demonstrated good concurrent validity with other outcome measures and high internal consistency. MCIDs values were found to be 13.8, 6.8 and 6.2 for the MFIS total, MFIS cognitive, and MFIS physical subscores respectively.
Conclusions:
The MFIS is a valid multidimensional measure of fatigue in PD with demonstrable MCID.
Insights
The Modified Fatigue Impact Scale (MFIS) is a valid tool for measuring Parkinson's disease (PD) fatigue. Its minimal clinically important difference (MCID) has been determined, aiding in therapeutic trial interpretation.
Area of Science:
- Neurology
- Psychometrics
- Clinical Trials
Background:
- Fatigue is a prevalent and disabling symptom in Parkinson's disease (PD).
- Currently, no evidence-based treatments exist for PD-related fatigue.
- Established fatigue scales lack a determined minimal clinically important difference (MCID), hindering clinical trial design and interpretation.
Purpose of the Study:
- To determine the minimal clinically important difference (MCID) for the Modified Fatigue Impact Scale (MFIS) in Parkinson's disease patients.
- To validate the MFIS as a measure of fatigue in PD.
Main Methods:
- Secondary data analysis of 94 PD participants from an acupuncture trial for PD fatigue.
- Utilized standard psychometric approaches for validity assessment.
- Employed an anchor-based approach to establish the MCID for the MFIS.
Main Results:
- The MFIS demonstrated strong concurrent validity with other outcome measures.
- High internal consistency was observed for the MFIS.
- Determined MCID values: 13.8 for total MFIS, 6.8 for MFIS cognitive subscore, and 6.2 for MFIS physical subscore.
Conclusions:
- The Modified Fatigue Impact Scale (MFIS) is a validated and multidimensional instrument for assessing fatigue in Parkinson's disease.
- The study successfully established demonstrable MCID values for the MFIS, crucial for clinical research.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

